HEADER ISOMERASE 10-FEB-04 1SB9 TITLE CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA UDP-N-ACETYLGLUCOSAMINE 4- TITLE 2 EPIMERASE COMPLEXED WITH UDP-GLUCOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: WBPP; COMPND 3 CHAIN: A; COMPND 4 EC: 5.1.3.7; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: WBPP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23 DERIVATIVE KEYWDS WBPP, EPIMERASE, 4-EPIMERASE, UDP-GLCNAC, SDR, GALE, NAD, SYK, KEYWDS 2 PSEUDOMONAS AERUGINOSA, UDP, N-ACETYLGLUCOSAMINE, UDP-GLC, GLUCOSE, KEYWDS 3 GALACTOSE, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.ISHIYAMA,C.CREUZENET,J.S.LAM,A.M.BERGHUIS REVDAT 3 13-JUL-11 1SB9 1 VERSN REVDAT 2 24-FEB-09 1SB9 1 VERSN REVDAT 1 25-MAY-04 1SB9 0 JRNL AUTH N.ISHIYAMA,C.CREUZENET,J.S.LAM,A.M.BERGHUIS JRNL TITL CRYSTAL STRUCTURE OF WBPP, A GENUINE UDP-N-ACETYLGLUCOSAMINE JRNL TITL 2 4-EPIMERASE FROM PSEUDOMONAS AERUGINOSA: SUBSTRATE JRNL TITL 3 SPECIFICITY IN UDP-HEXOSE 4-EPIMERASES. JRNL REF J.BIOL.CHEM. V. 279 22635 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15016816 JRNL DOI 10.1074/JBC.M401642200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 341340.930 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 14274 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1429 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2021 REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 220 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2654 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.28000 REMARK 3 B22 (A**2) : -11.31000 REMARK 3 B33 (A**2) : -7.97000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.73 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.160 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.860 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.780 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 44.95 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NAD_NI.PAR REMARK 3 PARAMETER FILE 3 : UPG_NI.PAR REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NAD_NI.TOP REMARK 3 TOPOLOGY FILE 3 : UPG_NI.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SB9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-FEB-04. REMARK 100 THE RCSB ID CODE IS RCSB021577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14274 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 45.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09600 REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1XEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 600, PHOSPHATE-CITRATE BUFFER , PH REMARK 280 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.58250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.58250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 30.49450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.85200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 30.49450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.85200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.58250 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 30.49450 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.85200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.58250 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 30.49450 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.85200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HOMODIMER GENERATED FROM THE REMARK 300 MONOMER IN THE ASYMMETRIC UNIT BY THE OPERATION: X, -Y, -Z+1 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 141.16500 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 MET A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 27 -72.97 -61.46 REMARK 500 SER A 103 110.72 82.73 REMARK 500 ASP A 110 68.15 -160.96 REMARK 500 HIS A 149 116.72 -32.18 REMARK 500 ASN A 195 73.64 39.57 REMARK 500 ASP A 235 71.25 -104.86 REMARK 500 ASN A 258 53.63 39.44 REMARK 500 ALA A 264 -157.87 -163.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 443 DISTANCE = 5.05 ANGSTROMS REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 UPG A 343 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 342 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UPG A 343 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SB8 RELATED DB: PDB REMARK 900 UDP-N-ACETYLGLUCOSAMINE 4-EPIMERASE COMPLEXED WITH NAD AND REMARK 900 UDP-N-ACETYLGALACTOSAMINE DBREF 1SB9 A 1 341 GB 20560072 AAM27817 1 341 SEQADV 1SB9 MET A -10 GB 20560072 INITIATING METHIONINE SEQADV 1SB9 HIS A -9 GB 20560072 EXPRESSION TAG SEQADV 1SB9 HIS A -8 GB 20560072 EXPRESSION TAG SEQADV 1SB9 HIS A -7 GB 20560072 EXPRESSION TAG SEQADV 1SB9 HIS A -6 GB 20560072 EXPRESSION TAG SEQADV 1SB9 HIS A -5 GB 20560072 EXPRESSION TAG SEQADV 1SB9 HIS A -4 GB 20560072 EXPRESSION TAG SEQADV 1SB9 GLY A -3 GB 20560072 CLONING ARTIFACT SEQADV 1SB9 SER A -2 GB 20560072 CLONING ARTIFACT SEQADV 1SB9 MET A -1 GB 20560072 CLONING ARTIFACT SEQADV 1SB9 GLY A 0 GB 20560072 CLONING ARTIFACT SEQRES 1 A 352 MET HIS HIS HIS HIS HIS HIS GLY SER MET GLY MET MET SEQRES 2 A 352 SER ARG TYR GLU GLU LEU ARG LYS GLU LEU PRO ALA GLN SEQRES 3 A 352 PRO LYS VAL TRP LEU ILE THR GLY VAL ALA GLY PHE ILE SEQRES 4 A 352 GLY SER ASN LEU LEU GLU THR LEU LEU LYS LEU ASP GLN SEQRES 5 A 352 LYS VAL VAL GLY LEU ASP ASN PHE ALA THR GLY HIS GLN SEQRES 6 A 352 ARG ASN LEU ASP GLU VAL ARG SER LEU VAL SER GLU LYS SEQRES 7 A 352 GLN TRP SER ASN PHE LYS PHE ILE GLN GLY ASP ILE ARG SEQRES 8 A 352 ASN LEU ASP ASP CYS ASN ASN ALA CYS ALA GLY VAL ASP SEQRES 9 A 352 TYR VAL LEU HIS GLN ALA ALA LEU GLY SER VAL PRO ARG SEQRES 10 A 352 SER ILE ASN ASP PRO ILE THR SER ASN ALA THR ASN ILE SEQRES 11 A 352 ASP GLY PHE LEU ASN MET LEU ILE ALA ALA ARG ASP ALA SEQRES 12 A 352 LYS VAL GLN SER PHE THR TYR ALA ALA SER SER SER THR SEQRES 13 A 352 TYR GLY ASP HIS PRO GLY LEU PRO LYS VAL GLU ASP THR SEQRES 14 A 352 ILE GLY LYS PRO LEU SER PRO TYR ALA VAL THR LYS TYR SEQRES 15 A 352 VAL ASN GLU LEU TYR ALA ASP VAL PHE SER ARG CYS TYR SEQRES 16 A 352 GLY PHE SER THR ILE GLY LEU ARG TYR PHE ASN VAL PHE SEQRES 17 A 352 GLY ARG ARG GLN ASP PRO ASN GLY ALA TYR ALA ALA VAL SEQRES 18 A 352 ILE PRO LYS TRP THR SER SER MET ILE GLN GLY ASP ASP SEQRES 19 A 352 VAL TYR ILE ASN GLY ASP GLY GLU THR SER ARG ASP PHE SEQRES 20 A 352 CYS TYR ILE GLU ASN THR VAL GLN ALA ASN LEU LEU ALA SEQRES 21 A 352 ALA THR ALA GLY LEU ASP ALA ARG ASN GLN VAL TYR ASN SEQRES 22 A 352 ILE ALA VAL GLY GLY ARG THR SER LEU ASN GLN LEU PHE SEQRES 23 A 352 PHE ALA LEU ARG ASP GLY LEU ALA GLU ASN GLY VAL SER SEQRES 24 A 352 TYR HIS ARG GLU PRO VAL TYR ARG ASP PHE ARG GLU GLY SEQRES 25 A 352 ASP VAL ARG HIS SER LEU ALA ASP ILE SER LYS ALA ALA SEQRES 26 A 352 LYS LEU LEU GLY TYR ALA PRO LYS TYR ASP VAL SER ALA SEQRES 27 A 352 GLY VAL ALA LEU ALA MET PRO TRP TYR ILE MET PHE LEU SEQRES 28 A 352 LYS HET NAD A 342 44 HET UPG A 343 36 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM UPG URIDINE-5'-DIPHOSPHATE-GLUCOSE HETSYN UPG URIDINE-5'-MONOPHOSPHATE GLUCOPYRANOSYL-MONOPHOSPHATE HETSYN 2 UPG ESTER FORMUL 2 NAD C21 H27 N7 O14 P2 FORMUL 3 UPG C15 H24 N2 O17 P2 FORMUL 4 HOH *142(H2 O) HELIX 1 1 SER A 3 LEU A 12 1 10 HELIX 2 2 GLY A 26 LEU A 39 1 14 HELIX 3 3 HIS A 53 VAL A 64 1 12 HELIX 4 4 SER A 65 SER A 70 1 6 HELIX 5 5 ASN A 81 ALA A 90 1 10 HELIX 6 6 SER A 103 ASP A 110 1 8 HELIX 7 7 ASP A 110 ILE A 119 1 10 HELIX 8 8 ILE A 119 ALA A 132 1 14 HELIX 9 9 SER A 144 GLY A 147 5 4 HELIX 10 10 SER A 164 GLY A 185 1 22 HELIX 11 11 ALA A 209 GLY A 221 1 13 HELIX 12 12 ILE A 239 THR A 251 1 13 HELIX 13 13 ALA A 252 ALA A 252 5 1 HELIX 14 14 GLY A 253 ARG A 257 5 5 HELIX 15 15 LEU A 271 GLU A 284 1 14 HELIX 16 16 ILE A 310 LEU A 317 1 8 HELIX 17 17 ASP A 324 LYS A 341 1 18 SHEET 1 A 7 PHE A 72 GLN A 76 0 SHEET 2 A 7 LYS A 42 ASP A 47 1 N VAL A 43 O LYS A 73 SHEET 3 A 7 VAL A 18 THR A 22 1 N TRP A 19 O LYS A 42 SHEET 4 A 7 TYR A 94 HIS A 97 1 O LEU A 96 N LEU A 20 SHEET 5 A 7 SER A 136 SER A 142 1 O THR A 138 N HIS A 97 SHEET 6 A 7 ILE A 189 TYR A 193 1 O LEU A 191 N ALA A 141 SHEET 7 A 7 GLN A 259 ILE A 263 1 O TYR A 261 N ARG A 192 SHEET 1 B 2 VAL A 196 PHE A 197 0 SHEET 2 B 2 CYS A 237 TYR A 238 1 O CYS A 237 N PHE A 197 SHEET 1 C 2 TYR A 225 ASN A 227 0 SHEET 2 C 2 VAL A 294 ARG A 296 1 O ARG A 296 N ILE A 226 SHEET 1 D 2 SER A 233 ARG A 234 0 SHEET 2 D 2 THR A 269 SER A 270 -1 O THR A 269 N ARG A 234 CISPEP 1 LEU A 152 PRO A 153 0 -0.05 SITE 1 AC1 32 GLY A 23 ALA A 25 GLY A 26 PHE A 27 SITE 2 AC1 32 ILE A 28 ASP A 47 ASN A 48 PHE A 49 SITE 3 AC1 32 ALA A 50 THR A 51 GLY A 52 GLY A 77 SITE 4 AC1 32 ASP A 78 ILE A 79 GLN A 98 ALA A 99 SITE 5 AC1 32 ALA A 100 THR A 117 ALA A 140 ALA A 141 SITE 6 AC1 32 TYR A 166 LYS A 170 TYR A 193 ASN A 195 SITE 7 AC1 32 VAL A 196 HOH A 344 HOH A 359 HOH A 370 SITE 8 AC1 32 HOH A 375 HOH A 397 HOH A 398 HOH A 407 SITE 1 AC2 16 ASN A 195 ALA A 209 VAL A 210 TRP A 214 SITE 2 AC2 16 TYR A 225 ILE A 226 ASN A 227 ARG A 234 SITE 3 AC2 16 LEU A 271 ARG A 299 ASP A 302 HOH A 348 SITE 4 AC2 16 HOH A 354 HOH A 374 HOH A 385 HOH A 451 CRYST1 60.989 95.704 141.165 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016396 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010449 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007084 0.00000 MASTER 321 0 2 17 13 0 12 6 0 0 0 28 END